Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...

The medicine's popularity has been driven by endorsements from celebrities and influencers. Read more at straitstimes.com.

New research suggests popular weight loss medications containing semaglutide may increase risk of rare vision condition, but ...

New research reveals Ozempic users may face twice the risk of developing a rare but irreversible form of vision loss. Danish ...

Azealia Banks accuses Elon Musk of drug use during a visit to Trump’s Mar-a-Lago estate and mocks his alleged use of the ...

Professor Yoni Freedhoff claimed that changing eating and exercise habits will never be as effective as weight-loss drugs ...

Both companies are longtime leaders in the pharmaceutical industry and have been making breakthroughs and delivering ...

There are those who believe that snacking must be avoided to achieve weight loss. While this is conventional wisdom, it is flawed because the impact of snacking depends on what is consumed.

Lisa Jarvis In a new study, an experimental obesity drug from Novo Nordisk called CagriSema allowed people to lose more than 20% of their body weight, on average, a result that caused the Danish ...

Eli Lilly (LLY) emerges among the top performers in Big Pharma in 2024 with obesity drug success, while Novo Nordisk (NVO) ...

Mounjaro, which has been dubbed the "King Kong" of weight-loss drugs, is considered more effective than its competitors with ...

The FDA has declared an end to the shortage of a popular obesity drug. The implications for consumers are complicated.